Martek Revenues Grow On International Demand For life’sDHA
This article was originally published in The Tan Sheet
Executive SummarySales of life'sDHA to international infant formula manufacturers helped drive nutritional oil developer Martek Biosciences' revenue up 18 percent to a record $82.9 million during its fiscal 2008 first quarter, the firm says
You may also be interested in...
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.